In conclusion, our research shows that decreased expression of XPC can increase the expression of stem cell markers (CD133, OCT4), which in turn affects the proliferation and migration of lung cancer cells, then has an adverse prognosis for patients with lung adenocarcinoma. The gene discussed is XPC; the disease is lung cancer.